STIMGENICS
Stimgenics is a private company that pioneered a novel spinal cord stimulation waveform known as Differential Target Multiplexed (DTM) Spinal Cord Stimulation.
STIMGENICS
Industry:
Biotechnology Medical
Address:
Bloomington, Illinois, United States
Country:
United States
Total Employee:
1+
Status:
Active
Similar Organizations
Ariagen
Ariagen is a biotech company that develops a novel class of small molecules as cancer immunotherapies.
Protein Sciences
Protein Sciences is a research company that provides the research and creation of new vaccines and other protective medicines.
Yatiri Bio
Yatiri Bio is a biotechnology company that delivers biomedical data solutions to the pharmaceutical industry.
More informations about "Stimgenics"
Medtronic acquires Stimgenics, pioneer of DTM, a novel spinal …
Stimgenics’ preclinical research on the neuronal-glial mechanism of action has been recognized at various medical society meetings.See details»
Stimgenics - Crunchbase Company Profile & Funding
Stimgenics is a private company that pioneered a novel spinal cord stimulation waveform known as Differential Target Multiplexed.See details»
Medtronic Acquires Stimgenics, Pioneer of DTM™, a Novel Spinal …
Jan 14, 2020 Medtronic plc (NYSE:MDT) announced it has acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel spinal cord …See details»
Medtronic Buys Spinal Cord Therapy Company, Adding To Its …
Jan 9, 2020 The company announced late Wednesday night that it acquired Stimgenics, a privately held enterprise that focuses on cutting-edge spinal cord stimulation (SCS) technology …See details»
Medtronic acquires Stimgenics, pioneer of Differential Target ...
Jan 9, 2020 Medtronic has acquired Stimgenics, a privately-held company that has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM) …See details»
Stimgenics SCS Programming Approach and Standard SCS ... - ICH …
Jul 12, 2018 The purpose of this investigational study is to study the effects of Stimgenics Spinal Cord Stimulation (SGX-SCS) in subjects with chronic, intractable pain of the trunk with lower …See details»
Medtronic Acquires Stimgenics | Mergr M&A Deal Summary
Stimgenics LLC is a privately-held company that has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM™) Spinal Cord Stimulation. …See details»
Press Releases | Medtronic
Jan 8, 2020 Stimgenics, LLC is a private company based in Bloomington, Illinois, that pioneered a novel spinal cord stimulation waveform known as Differential Target Multiplexed (DTM) …See details»
Medtronic buys Stimgenics to boost pain therapies business
Jan 9, 2020 Medtronic buys Stimgenics to boost pain therapies business Irish medical device maker Medtronic has acquired privately held American firm Stimgenics for an undisclosed …See details»
Medtronic buys new spinal cord tech to boost pain therapies unit
Jan 9, 2020 Amid a broader slowdown in the spinal cord stimulation market, Medtronic is acquiring technology from Stimgenics that offers a new way of programming its Intellis implant.See details»
Glia, non-neuronal cells, Stimgenics, Medtronic DTM, Interleukin 10
Stimgenics’ preclinical research on the neuronal-glial mechanism of action has been recognized at various medical society meetings. Over the course of the past two years, the team has …See details»
Medtronic buys new spinal cord tech to boost pain therapies unit
Dive Insight: Spinal cord stimulation is a treatment that thwarts pain signals before they reach the brain by using an implanted device to send electrical pulses to the spinal cord area. Medtronic …See details»
Medtronic acquires Stimgenics - 2020-01-08 - Crunchbase
Jan 8, 2020 Overview Acquired Organization: Stimgenics Stimgenics is a private company that pioneered a novel spinal cord stimulation waveform known as Differential Target Multiplexed.See details»
Stimgenics Open-Label, Post Market Study | Smart Patients
The purpose of this investigational study is to study the effects of Stimgenics Spinal Cord Stimulation (SGX-SCS) in subjects with chronic, intractable pain of the trunk with lower limb …See details»
STIMGENICS, LLC Employer Identification Number EIN
STIMGENICS, LLC is a USA domiciled entity or foreign entity operating in the USA. The EIN ihas been issued by the IRSSee details»
SlimGenics Direct | Good For You. Good For Life
Since 2003, SlimGenics has helped tens of thousands of people live their best life with top quality nutritional supplements, people-proven weight loss and healthy detoxification programs. This …See details»
Medtronic buys DTM spinal cord stimulation therapy provider …
Jan 9, 2020 Medical technology firm Medtronic has acquired US privately-held company Stimgenics for an undisclosed sum. Based in Bloomington of Illinois, Stimgenics has …See details»
Medtronic Acquires Stimgenics, Pioneer of DTM™, a Novel
Jan 8, 2020 Stimgenics, LLC is a private company based in Bloomington, Illinois, that pioneered a novel spinal cord stimulation waveform known as Differential Target Multiplexed (DTM) …See details»
Press Releases | Medtronic
DUBLIN, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced it has acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has …See details»
Stimgenics Open-Label, Post Market Study
Stimgenics Open-Label, Post Market Study: A Clinical Trial to Study the Effects of Stimgenics Spinal Cord Stimulation (SGX-SCS) Programs in Treating Intractable Chronic Back Pain The …See details»